PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2013

Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 23474678 ↗2013Reported benefit

Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury.

MouseTBIControlled cortical impactC57BL/6NMaleSubcutaneous injectionBortezomib 0.2 mg/kg plus dexamethasone 10 mg/kg30 minutes after injury

Model: Mechanical brain lesion by controlled cortical impact

Proteasomal glucocorticoid receptor degradation was established in brain endothelial cells after controlled cortical impact. Combining bortezomib with dexamethasone restored occludin levels, improved blood-brain barrier integrity, reduced oedema formation and limited neuronal damage, offering a mec…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.